Cadila Healthcare Limited has informed the Exchange about press release dated 07-Mar-2022 titled Zydus to launch Oxemia (Desidustat) a breakthrough treatment for Anemia in patients suffering from Chronic Kidney Disease (CKD)
Press Release Mar 07 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Feb 23 2022
- Press Release Feb 14 2022
- Press Release Feb 02 2022
- Press Release Jan 20 2022
- Press Release Dec 31 2021
Later from Zydus Lifesciences
- Press Release Mar 08 2022
- Press Release Mar 09 2022
- Press Release Mar 14 2022
- Press Release Mar 21 2022
- Press Release Apr 01 2022
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences